NVCR primed for an extended run

NASDAQ:NVCR   NovoCure Limited
Kept the chart simple but there are a lot of bullish aspects at play here:

- ready for markup after an accumulation phase
- coming off a wave 5 correction apprx. 0.786 off the highs last June
- looking at weekly chart you’ll see a larger running flat structure
- earnings as a catalyst and overall great company!

*Initial Target by Apr 14 = 99
** Target range by 5/20/2022 = 108-116

Would love to hear your thoughts on this.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.